Evotec AG operates in the Pharmaceutical preparations sector. Evotec AG (Evotec) is a drug discovery and development company focused on providing integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry. In addition, the Company has a small number of its own drug candidates at various stages of development either partnered or available for partnering. The Company provides integrated solutions to the pharmaceutical and biotechnology industry from target to clinical development through a range of capabilities and capacities, including early-stage assay development and screening, fragment-based drug discovery through to medicinal chemistry and in vivo pharmacology. Effective August 31, 2009, the Company acquired 70% of the shares in Research Support International Private Limited, Thane, India (RSIPL). In April 2011, it acquired Kinaxo Biotechnologies GmbH. On January 24, 2012, the Company announced the acquisition of all remaining shares in DeveloGen AG. In our complete report available for purchase the company is compared to: Hansen Sicherheitstechnik AG, Lewag Holding AG and Bruder Mannesmann Ag.